India · Delayed Price · Currency is INR Gennex Laboratories Company Description
Gennex Laboratories Limited manufactures and sells bulk drugs, intermediates, and biotech products.
The company offers Guaifenesin, an expectorant used as a mucolyte; Methocarbamol for skeletal muscle relaxant; Fexofenadine Hcl for treating antihistamines; Phenazopyridine Hcl for the treatment of urinary tract analgesic; Fluconazole for antifungals; Melitracen Hcl for treating tricyclic antidepressant; Sertraline Hcl, a selective serotonin reuptake inhibitor; Chlorphenesin and Mephenesin for muscle relaxant; and Allopurinol, a xanthine oxidase inhibitor.
It has operations in India, Algeria, Bangladesh, Barzil, Bolivia, Colombia, the Czech Republic, Egypt, El Salvador, Germany, Guatemala City, Mexico, Peru, Spain, Turkey, Thailand, the United Arab Emirates, and Vietnam.
Gennex Laboratories Limited was formerly known as Prudential Pharmaceuticals Limited and changed its name to Gennex Laboratories Limited in September 2007.
Gennex Laboratories Limited was incorporated in 1985 and is based in Hyderabad, India.
| Country | India |
| Founded | 1985 |
| Industry | Pharmaceutical Preparations |
| Employees | 115 |
| CEO | Arihant Baid |
Contact Details
Address: Plot No. 144, Akash Ganga Complex Hyderabad, 500073 India | |
| Phone | 91 40 6733 4400 |
| Website | gennexlab.com |
Stock Details
| Ticker Symbol | 531739 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Arihant Baid | Chief Executive Officer |
| Akkali Kumar | Chief Financial Officer |
| K. V. L. Bhaswanth | Chief Operating Officer |